-
1
-
-
0034871451
-
A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival
-
Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198
-
(2001)
J Neurosurg
, vol.95
, pp. 190-198
-
-
Lacroix, M.1
Abi-Said, D.2
Fourney, D.R.3
Gokaslan, Z.L.4
Shi, W.5
DeMonte, F.6
Lang, F.F.7
McCutcheon, I.E.8
Hassenbusch, S.J.9
Holland, E.10
Hess, K.11
Michael, C.12
Miller, D.13
Sawaya, R.14
-
2
-
-
33747153371
-
Treatment options for glioblastoma
-
Chamberlain MC (2006) Treatment options for glioblastoma. Neurosurg Focus 20:E2
-
(2006)
Neurosurg Focus
, vol.20
-
-
Chamberlain, M.C.1
-
3
-
-
0026100939
-
Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas
-
Brem H, Mahaley MS Jr, Vick NA, Black KL, Schold SC Jr, Burger PC, Friedman AH, Ciric IS, Eller TW, Cozzens JW et al (1991) Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 74:441-446
-
(1991)
J Neurosurg
, vol.74
, pp. 441-446
-
-
Brem, H.1
Mahaley Jr., M.S.2
Vick, N.A.3
Black, K.L.4
Schold Jr., S.C.5
Burger, P.C.6
Friedman, A.H.7
Ciric, I.S.8
Eller, T.W.9
Cozzens, J.W.10
-
4
-
-
0023117480
-
Direct delivery of medication into a brain tumor through multiple chronically implanted catheters
-
Bouvier G, Penn RD, Kroin JS, Beique R, Guerard MJ (1987) Direct delivery of medication into a brain tumor through multiple chronically implanted catheters. Neurosurgery 20:286-291
-
(1987)
Neurosurgery
, vol.20
, pp. 286-291
-
-
Bouvier, G.1
Penn, R.D.2
Kroin, J.S.3
Beique, R.4
Guerard, M.J.5
-
5
-
-
23444437213
-
Convection-enhanced delivery of macromolecules in the brain
-
Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH (1994) Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 91:2076-2080
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 2076-2080
-
-
Bobo, R.H.1
Laske, D.W.2
Akbasak, A.3
Morrison, P.F.4
Dedrick, R.L.5
Oldfield, E.H.6
-
6
-
-
34147138870
-
Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors
-
Ferguson S, Lesniak MS (2007) Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors. Curr Drug Deliv 4:169-180
-
(2007)
Curr Drug Deliv
, vol.4
, pp. 169-180
-
-
Ferguson, S.1
Lesniak, M.S.2
-
7
-
-
0030954720
-
Chronic interstitial infusion of protein to primate brain: Determination of drug distribution and clearance with single-photon emission computerized tomography imaging
-
Laske DW, Morrison PF, Lieberman DM, Corthesy ME, Reynolds JC, Stewart-Henney PA, Koong SS, Cummins A, Paik CH, Oldfield EH (1997) Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging. J Neurosurg 87:586-594
-
(1997)
J Neurosurg
, vol.87
, pp. 586-594
-
-
Laske, D.W.1
Morrison, P.F.2
Lieberman, D.M.3
Corthesy, M.E.4
Reynolds, J.C.5
Stewart-Henney, P.A.6
Koong, S.S.7
Cummins, A.8
Paik, C.H.9
Oldfield, E.H.10
-
8
-
-
0032949676
-
Variables affecting convection-enhanced delivery to the striatum: A systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time
-
Chen MY, Lonser RR, Morrison PF, Governale LS, Oldfield EH (1999) Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg 90:315-320
-
(1999)
J Neurosurg
, vol.90
, pp. 315-320
-
-
Chen, M.Y.1
Lonser, R.R.2
Morrison, P.F.3
Governale, L.S.4
Oldfield, E.H.5
-
9
-
-
0029001712
-
Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion
-
Lieberman DM, Laske DW, Morrison PF, Bankiewicz KS, Oldfield EH (1995) Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. J Neurosurg 82:1021-1029
-
(1995)
J Neurosurg
, vol.82
, pp. 1021-1029
-
-
Lieberman, D.M.1
Laske, D.W.2
Morrison, P.F.3
Bankiewicz, K.S.4
Oldfield, E.H.5
-
10
-
-
0028144703
-
High-flow microinfusion: Tissue penetration and pharmacodynamics
-
Morrison PF, Laske DW, Bobo H, Oldfield EH, Dedrick RL (1994) High-flow microinfusion: tissue penetration and pharmacodynamics. Am J Physiol 266:R292-R305
-
(1994)
Am J Physiol
, vol.266
-
-
Morrison, P.F.1
Laske, D.W.2
Bobo, H.3
Oldfield, E.H.4
Dedrick, R.L.5
-
11
-
-
0036053691
-
Local treatment of brain tumors with targeted chimera cytotoxic proteins
-
Debinski W (2002) Local treatment of brain tumors with targeted chimera cytotoxic proteins. Cancer Invest 20:801-809
-
(2002)
Cancer Invest
, vol.20
, pp. 801-809
-
-
Debinski, W.1
-
12
-
-
0344444830
-
Interleukin-4Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy
-
Kawakami M, Kawakami K, Puri RK (2003) Interleukin-4Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy. J Neurooncol 65:15-25
-
(2003)
J Neurooncol
, vol.65
, pp. 15-25
-
-
Kawakami, M.1
Kawakami, K.2
Puri, R.K.3
-
13
-
-
4644221708
-
Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin
-
Kioi M, Kawakami K, Puri RK (2004) Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin. Clin Cancer Res 10:6231-6238
-
(2004)
Clin Cancer Res
, vol.10
, pp. 6231-6238
-
-
Kioi, M.1
Kawakami, K.2
Puri, R.K.3
-
14
-
-
33947547455
-
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: A report by the Cintredekin Besudotox Intraparenchymal Study Group
-
Kunwar S, Prados MD, Chang SM, Berger MS, Lang FF, Piepmeier JM, Sampson JH, Ram Z, Gutin PH, Gibbons RD, Aldape KD, Croteau DJ, Sherman JW, Puri RK (2007) Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol 25:837-844
-
(2007)
J Clin Oncol
, vol.25
, pp. 837-844
-
-
Kunwar, S.1
Prados, M.D.2
Chang, S.M.3
Berger, M.S.4
Lang, F.F.5
Piepmeier, J.M.6
Sampson, J.H.7
Ram, Z.8
Gutin, P.H.9
Gibbons, R.D.10
Aldape, K.D.11
Croteau, D.J.12
Sherman, J.W.13
Puri, R.K.14
-
15
-
-
0031451777
-
Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors
-
Laske DW, Youle RJ, Oldfield EH (1997) Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med 3:1362-1368
-
(1997)
Nat Med
, vol.3
, pp. 1362-1368
-
-
Laske, D.W.1
Youle, R.J.2
Oldfield, E.H.3
-
16
-
-
0344876636
-
Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas
-
Weaver M, Laske DW (2003) Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas. J Neurooncol 65:3-13
-
(2003)
J Neurooncol
, vol.65
, pp. 3-13
-
-
Weaver, M.1
Laske, D.W.2
-
17
-
-
1442282498
-
Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: A phase I/II clinical study
-
Lidar Z, Mardor Y, Jonas T, Pfeffer R, Faibel M, Nass D, Hadani M, Ram Z (2004) Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. J Neurosurg 100:472-479
-
(2004)
J Neurosurg
, vol.100
, pp. 472-479
-
-
Lidar, Z.1
Mardor, Y.2
Jonas, T.3
Pfeffer, R.4
Faibel, M.5
Nass, D.6
Hadani, M.7
Ram, Z.8
-
18
-
-
0035394313
-
Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging
-
Mardor Y, Roth Y, Lidar Z, Jonas T, Pfeffer R, Maier SE, Faibel M, Nass D, Hadani M, Orenstein A, Cohen JS, Ram Z (2001) Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res 61:4971-4973
-
(2001)
Cancer Res
, vol.61
, pp. 4971-4973
-
-
Mardor, Y.1
Roth, Y.2
Lidar, Z.3
Jonas, T.4
Pfeffer, R.5
Maier, S.E.6
Faibel, M.7
Nass, D.8
Hadani, M.9
Orenstein, A.10
Cohen, J.S.11
Ram, Z.12
-
19
-
-
1542428592
-
Molecular imaging and treatment of malignant gliomas following adenoviral transfer of the herpes simplex virus-thymidine kinase gene and the somatostatin receptor subtype 2 gene
-
Verwijnen SM, Sillevis Smith PA, Hoeben RC, Rabelink MJ, Wiebe L, Curiel DT, Hemminki A, Krenning EP, de Jong M (2004) Molecular imaging and treatment of malignant gliomas following adenoviral transfer of the herpes simplex virus-thymidine kinase gene and the somatostatin receptor subtype 2 gene. Cancer Biother Radiopharm 19:111-120
-
(2004)
Cancer Biother Radiopharm
, vol.19
, pp. 111-120
-
-
Verwijnen, S.M.1
Sillevis Smith, P.A.2
Hoeben, R.C.3
Rabelink, M.J.4
Wiebe, L.5
Curiel, D.T.6
Hemminki, A.7
Krenning, E.P.8
De Jong, M.9
-
20
-
-
20044374196
-
Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: Initial experience in 51 patients
-
Discussion 1252-1243
-
Patel SJ, Shapiro WR, Laske DW, Jensen RL, Asher AL, Wessels BW, Carpenter SP, Shan JS (2005) Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients. Neurosurgery 56:1243-1252; discussion 1252-1243
-
(2005)
Neurosurgery
, vol.56
, pp. 1243-1252
-
-
Patel, S.J.1
Shapiro, W.R.2
Laske, D.W.3
Jensen, R.L.4
Asher, A.L.5
Wessels, B.W.6
Carpenter, S.P.7
Shan, J.S.8
-
21
-
-
77955608850
-
Poor drug distribution as a possible explanation for the results of the PRECISE trial
-
Sampson JH, Archer G, Pedain C, Wembacher-Schroder E, Westphal M, Kunwar S, Vogelbaum MA, Coan A, Herndon JE, Raghavan R, Brady ML, Reardon DA, Friedman AH, Friedman HS, Rodriguez-Ponce MI, Chang SM, Mittermeyer S, Croteau D, Puri RK (2010) Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg 113:301-309
-
(2010)
J Neurosurg
, vol.113
, pp. 301-309
-
-
Sampson, J.H.1
Archer, G.2
Pedain, C.3
Wembacher-Schroder, E.4
Westphal, M.5
Kunwar, S.6
Vogelbaum, M.A.7
Coan, A.8
Herndon, J.E.9
Raghavan, R.10
Brady, M.L.11
Reardon, D.A.12
Friedman, A.H.13
Friedman, H.S.14
Rodriguez-Ponce, M.I.15
Chang, S.M.16
Mittermeyer, S.17
Croteau, D.18
Puri, R.K.19
-
22
-
-
33846990103
-
Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: Descriptive effects of target anatomy and catheter positioning
-
discussion ONS98-89
-
Sampson JH, Brady ML, Petry NA, Croteau D, Friedman AH, Friedman HS, Wong T, Bigner DD, Pastan I, Puri RK, Pedain C (2007) Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning. Neurosurgery 60:ONS8998; discussion ONS98-89
-
(2007)
Neurosurgery
, vol.60
-
-
Sampson, J.H.1
Brady, M.L.2
Petry, N.A.3
Croteau, D.4
Friedman, A.H.5
Friedman, H.S.6
Wong, T.7
Bigner, D.D.8
Pastan, I.9
Puri, R.K.10
Pedain, C.11
-
23
-
-
0142182636
-
Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats
-
Degen JW, Walbridge S, Vortmeyer AO, Oldfield EH, Lonser RR (2003) Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. J Neurosurg 99:893-898
-
(2003)
J Neurosurg
, vol.99
, pp. 893-898
-
-
Degen, J.W.1
Walbridge, S.2
Vortmeyer, A.O.3
Oldfield, E.H.4
Lonser, R.R.5
|